It was shown that antioxidant Trx expression correlates with Treg representation in clinical samples of metastatic melanoma and that modulation of Trx influences the induction of Tregs and the generation of an immunotolerant cytokine profile. The gene discussed is TXN; the disease is metastatic melanoma.